Literature DB >> 3072138

Immunohistochemical identification of infiltrating mononuclear cells in tubulointerstitial nephritis associated with Sjögren's syndrome.

R Matsumura1, Y Kondo, T Sugiyama, M Sueishi, T Koike, K Takabayashi, H Tomioka, S Yoshida, H Tsuchida.   

Abstract

Using monoclonal antibodies, immunoperoxidase analysis was performed on eight renal biopsy samples obtained from patients with Sjögren's syndrome-associated tubulointerstitial nephritis. In all cases the interstitial infiltrates were predominantly CD5-positive T-cells (mean 66%), whereas both B-cell (CD19-positive) and monocyte (CD15-positive) populations participated to a lesser degree. CD16-positive NK/K cells were rarely encountered. The CD4/CD8 ratio was consistently higher than 1.0 (mean 2.08). The lymphocytes which invaded the tubular epithelial cells to present a feature of tubulitis were CD8-positive, suggesting that they were cytotoxic T-cells. These results were in general accord with those obtained in the salivary glands of patients with Sjögren's syndrome. It was thus concluded that the same immunological process was probably operative in the renal tubulointerstitial tissue as in the salivary glands to induce the characteristic tissue changes of Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072138

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

1.  Renal tubular dysfunction in primary Sjögren's syndrome: clinical studies in 27 patients.

Authors:  P P Viergever; T J Swaak
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

2.  Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome.

Authors:  R Matsumura; K Umemiya; T Goto; T Nakazawa; M Kagami; H Tomioka; E Tanabe; T Sugiyama; M Sueishi
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

3.  Hypokalemic periodic paralysis in Sjogren's syndrome secondary to distal renal tubular acidosis.

Authors:  Hakkı Yılmaz; Mustafa Kaya; Mustafa Özbek; Kemal ÜUreten; İ Safa Yıldırım
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

Review 4.  Distal renal tubular acidosis: the value of urinary pH, PCO2 and NH4+ measurements.

Authors:  O Wrong
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 5.  Targeting the B cell in vasculitis.

Authors:  Michael Walsh; David Jayne
Journal:  Pediatr Nephrol       Date:  2008-10-18       Impact factor: 3.714

6.  Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.

Authors:  Saugar Maripuri; Joseph P Grande; Thomas G Osborn; Fernando C Fervenza; Eric L Matteson; James V Donadio; Marie C Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 8.237

7.  Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment.

Authors:  Rhys D R Evans; Christopher M Laing; Coziana Ciurtin; Stephen B Walsh
Journal:  BMC Musculoskelet Disord       Date:  2016-01-05       Impact factor: 2.362

8.  Ectopic germinal center and megalin defect in primary Sjogren syndrome with renal Fanconi syndrome.

Authors:  Jing Wang; Yubing Wen; Mengyu Zhou; Xiaoxiao Shi; Lanping Jiang; Mingxi Li; Yang Yu; Xuemei Li; Xuewang Li; Wen Zhang; Andrew L Lundquist; Limeng Chen
Journal:  Arthritis Res Ther       Date:  2017-06-02       Impact factor: 5.156

9.  Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis.

Authors:  Ruping Hong; Dong Xu; Evelyn Hsieh; Yirong Xiang; Jiuliang Zhao; Qian Wang; Xinping Tian; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  Front Med (Lausanne)       Date:  2020-11-26

10.  Increased Risks of Spontaneous Bacterial Peritonitis and Interstitial Lung Disease in Primary Biliary Cirrhosis Patients With Concomitant Sjögren Syndrome.

Authors:  Chun-Ting Chen; Yu-Chen Tseng; Chih-Wei Yang; Hsuan-Hwai Lin; Peng-Jen Chen; Tien-Yu Huang; Yu-Lueng Shih; Wei-Kuo Chang; Tsai-Yuan Hsieh; Heng-Cheng Chu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.